{
  "openalex_id": "W4322769470",
  "doi": "https://doi.org/10.1158/1538-7445.sabcs22-pd7-03",
  "title": "Abstract PD7-03: Translational Breast Cancer Research Consortium Trial 022: Neratinib and Trastuzumab-Emtansine for HER2+ Breast Cancer Brain Metastases (BCBM)",
  "abstract": "Abstract PURPOSE: Treatment options for patients (pts) with HER2+ BCBM remain limited. We previously reported that neratinib monotherapy is associated with a volumetric central nervous system objective response rate (CNS ORR) of 8%, whereas the combination of neratinib and capecitabine resulted in a volumetric CNS ORR of 49% (in lapatinib-naïve pts). Preclinical data suggest that neratinib may overcome resistance to trastuzumab-emtansine (T-DM1) and that the combination has potential CNS efficacy. Here, we report results of neratinib plus T-DM1 in pts with HER2+ BCBM. PATIENTS AND METHODS: In this prospective, multicenter, phase II study, pts with measurable HER2+ BCBM received neratinib 160 mg orally once daily plus T-DM1 3.6 mg/kg IV every 21 days in three parallel-enrolling cohorts. Cohort 4A enrolled pts with previously untreated brain metastases. Cohort 4B enrolled pts with BCBM progressing after prior local CNS-directed therapy without prior exposure to T-DM1. Cohort 4C enrolled pts with BCBM progressing after prior local CNS-directed therapy who had previous exposure to T-DM1. Diarrhea prophylaxis with colestipol and loperamide was required during cycle 1. Cohorts 4A and 4B were single-stage with a planned enrollment of 20 patients; cohort 4C had a two-stage design, with a requirement for at least 1 of the first 9 pts to achieve a response in order to enroll a total of 24 patients. The primary endpoint was Response Assessment in Neuro-Oncology-Brain Metastases (RANO BM) in each cohort separately. Correlative studies included patient-reported outcomes (PROs) for gastrointestinal toxicity. RESULTS: We enrolled 6, 17, and 21 patients to cohorts 4A, 4B, and 4C, during 11/07/2018 – 11/01/2021. Enrollment was stopped prematurely due to slow accrual. Across Cohorts 4A-4C, the median number of prior lines of chemotherapy prior to enrollment was 2 (range 1-10); 25% received prior lapatinib and no patients received prior tucatinib. In cohorts 4B and 4C (prior CNS-treated cohorts), 33% had prior CNS surgery and &amp;gt;94% had prior CNS radiation. Among evaluable patients, CNS ORR in cohorts 4A (n=6), 4B (n=16), and 4C (n=21) was 50.0% (95% CI 18.8- 81.2%), 25.0% (95% CI 8.3-52.6%), and 38.1% (95% CI 19.0-61.3%), respectively. Median (range) number of cycles completed for 4A, 4B, and 4C was 4.5 (1-15), 4 (range 0-49+), and 6 (0-23); three patients on Cohort 4B remain on protocol therapy (cycles 14, 45, and 49). The overall survival at 12-months for cohorts 4A, 4B, and 4C was 83.3% (95% CI, 58.3-100%), 86.2% (95% CI 70-100%), and 83.3% (95% CI 67.6-100%). Diarrhea was the most common grade 3 toxicity (19.0–33.3% across cohorts); one grade 4 liver function event occurred in cohort 4B. Updated efficacy results will be reported at the meeting; PRO analyses are ongoing. CONCLUSION: Intracranial activity was observed for the combination of neratinib plus T-DM1 across all three enrolled cohorts, including those with prior T-DM1 exposure, suggesting synergistic effects of this treatment combination. Our data provide additional evidence for consideration of neratinib-based combinations in pts with HER2+ BCBM. Citation Format: Rachel Freedman, Siyang Ren, Nabihah Tayob, Rebecca Gelman, Karen L. Smith, Raechel Davis, Alyssa Pereslete, Victoria Attaya, Christine Cotter, Wendy Y. Chen, Cesar Augusto Santa-Maria, Catherine Van Poznak, Beverly Moy, Adam M. Brufsky, Michelle Melisko, Ciara C. O’Sullivan, Nadia Ashai, Yasmeen Rauf, Julie Nangia, Dario Trapani, Jennifer Savoie, Robyn Burns, Antonio C. Wolff, Eric Winer, Mothaffar Rimawi, Ian Krop, Nancy U. Lin. Translational Breast Cancer Research Consortium Trial 022: Neratinib and Trastuzumab-Emtansine for HER2+ Breast Cancer Brain Metastases (BCBM) [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr PD7-03.",
  "authors": [
    {
      "display_name": "Rachel A. Freedman",
      "id": "A5080530218",
      "orcid": "https://orcid.org/0000-0003-0460-674X",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Rachel Freedman"
    },
    {
      "display_name": "Siyang Ren",
      "id": "A5074064318",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Siyang Ren"
    },
    {
      "display_name": "Nabihah Tayob",
      "id": "A5062515397",
      "orcid": "https://orcid.org/0000-0001-6088-167X",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Nabihah Tayob"
    },
    {
      "display_name": "Rebecca Gelman",
      "id": "A5062329369",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Rebecca Gelman"
    },
    {
      "display_name": "Karen L. Smith",
      "id": "A5076076101",
      "orcid": "https://orcid.org/0000-0002-6687-0119",
      "institutions": [
        {
          "id": "I4210164401",
          "display_name": "Sidney Kimmel Comprehensive Cancer Center",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Karen L. Smith"
    },
    {
      "display_name": "Raechel Davis",
      "id": "A5000879533",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Raechel Davis"
    },
    {
      "display_name": "Alyssa Pereslete",
      "id": "A5053815800",
      "orcid": "https://orcid.org/0000-0001-7995-7507",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Alyssa Pereslete"
    },
    {
      "display_name": "Victoria Attaya",
      "id": "A5087930566",
      "orcid": "https://orcid.org/0009-0004-3440-0501",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Victoria Attaya"
    },
    {
      "display_name": "Christine M. Cotter",
      "id": "A5077801591",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Christine Cotter"
    },
    {
      "display_name": "Wendy Y. Chen",
      "id": "A5115883330",
      "orcid": "https://orcid.org/0000-0002-6946-1206",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Wendy Y. Chen"
    },
    {
      "display_name": "Cesar Augusto Santa-Maria",
      "id": "A5112829137",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Cesar Augusto Santa-Maria"
    },
    {
      "display_name": "Catherine Van Poznak",
      "id": "A5035798552",
      "orcid": "https://orcid.org/0000-0001-5523-6908",
      "institutions": [
        {
          "id": "I27837315",
          "display_name": "University of Michigan",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Catherine Van Poznak"
    },
    {
      "display_name": "Beverly Moy",
      "id": "A5017550097",
      "orcid": "https://orcid.org/0000-0003-3472-1140",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Beverly Moy"
    },
    {
      "display_name": "Adam Brufsky",
      "id": "A5044108002",
      "orcid": "https://orcid.org/0000-0001-8080-7960",
      "institutions": [
        {
          "id": "I4210134769",
          "display_name": "University of Pittsburgh Medical Center",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I4210128526",
          "display_name": "UPMC Hillman Cancer Center",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Adam M. Brufsky"
    },
    {
      "display_name": "Michelle Melisko",
      "id": "A5000761973",
      "orcid": "https://orcid.org/0000-0002-8729-4667",
      "institutions": [
        {
          "id": "I180670191",
          "display_name": "University of California, San Francisco",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Michelle Melisko"
    },
    {
      "display_name": "Ciara C. O’Sullivan",
      "id": "A5058935870",
      "orcid": "https://orcid.org/0000-0001-6069-9800",
      "institutions": [
        {
          "id": "I1330342723",
          "display_name": "Mayo Clinic",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Ciara C. O’Sullivan"
    },
    {
      "display_name": "Nadia Ashai",
      "id": "A5045793143",
      "orcid": "https://orcid.org/0000-0002-2952-6941",
      "institutions": [
        {
          "id": "I184565670",
          "display_name": "Georgetown University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I2802534011",
          "display_name": "MedStar Georgetown University Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Nadia Ashai"
    },
    {
      "display_name": "Yasmeen Rauf",
      "id": "A5113967646",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Yasmeen Rauf"
    },
    {
      "display_name": "Julie R. Nangia",
      "id": "A5007261291",
      "orcid": "https://orcid.org/0000-0002-8326-2254",
      "institutions": [
        {
          "id": "I181547552",
          "display_name": "Baylor College of Medicine",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Julie Nangia"
    },
    {
      "display_name": "Dario Trapani",
      "id": "A5035150606",
      "orcid": "https://orcid.org/0000-0003-1672-9560",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Dario Trapani"
    },
    {
      "display_name": "Jennifer Savoie",
      "id": "A5110273759",
      "orcid": null,
      "institutions": [
        {
          "id": "I196764719",
          "display_name": "Breast Cancer Research Foundation",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jennifer Savoie"
    },
    {
      "display_name": "Robyn Burns",
      "id": "A5058186688",
      "orcid": null,
      "institutions": [
        {
          "id": "I196764719",
          "display_name": "Breast Cancer Research Foundation",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Robyn Burns"
    },
    {
      "display_name": "Antonio C. Wolff",
      "id": "A5026024346",
      "orcid": "https://orcid.org/0000-0003-3734-1063",
      "institutions": [
        {
          "id": "I6059380",
          "display_name": "University of Baltimore",
          "country_code": "US",
          "type": "education"
        },
        {
          "id": "I145311948",
          "display_name": "Johns Hopkins University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Antonio C. Wolff"
    },
    {
      "display_name": "Eric P. Winer",
      "id": "A5070245248",
      "orcid": "https://orcid.org/0000-0002-8819-1723",
      "institutions": [
        {
          "id": "I2802730090",
          "display_name": "Yale Cancer Center",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Eric Winer"
    },
    {
      "display_name": "Mothaffar F. Rimawi",
      "id": "A5072850149",
      "orcid": "https://orcid.org/0000-0002-4284-5656",
      "institutions": [
        {
          "id": "I181547552",
          "display_name": "Baylor College of Medicine",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mothaffar Rimawi"
    },
    {
      "display_name": "Ian E. Krop",
      "id": "A5032785430",
      "orcid": "https://orcid.org/0000-0002-6380-5944",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Ian Krop"
    },
    {
      "display_name": "Nancy U. Lin",
      "id": "A5049174232",
      "orcid": "https://orcid.org/0000-0003-2263-5413",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Nancy U. Lin"
    }
  ],
  "publication_year": 2023,
  "publication_date": "2023-03-01",
  "type": "article",
  "cited_by_count": 5,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S168522863",
    "display_name": "Cancer Research",
    "issn_l": "0008-5472",
    "issn": [
      "0008-5472",
      "1538-7445"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320273"
  },
  "volume": "83",
  "issue": "5_Supplement",
  "first_page": "PD7",
  "last_page": "03",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2779413316",
      "display_name": "Neratinib",
      "level": 5,
      "score": 0.93457174
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.8443905
    },
    {
      "id": "C2777329042",
      "display_name": "Lapatinib",
      "level": 5,
      "score": 0.7981974
    },
    {
      "id": "C72563966",
      "display_name": "Cohort",
      "level": 2,
      "score": 0.60872555
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.58468574
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.5594029
    },
    {
      "id": "C2777909004",
      "display_name": "Capecitabine",
      "level": 4,
      "score": 0.52178645
    },
    {
      "id": "C530470458",
      "display_name": "Breast cancer",
      "level": 3,
      "score": 0.51658165
    },
    {
      "id": "C2779786085",
      "display_name": "Trastuzumab",
      "level": 4,
      "score": 0.51308644
    },
    {
      "id": "C203092338",
      "display_name": "Clinical endpoint",
      "level": 3,
      "score": 0.50761473
    },
    {
      "id": "C2775930923",
      "display_name": "Metastatic breast cancer",
      "level": 4,
      "score": 0.43156618
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.391872
    },
    {
      "id": "C535046627",
      "display_name": "Clinical trial",
      "level": 2,
      "score": 0.24070644
    },
    {
      "id": "C526805850",
      "display_name": "Colorectal cancer",
      "level": 3,
      "score": 0.1748892
    }
  ],
  "topics": [
    {
      "id": "T11600",
      "display_name": "Brain Metastases and Treatment",
      "score": 0.9987
    },
    {
      "id": "T12829",
      "display_name": "Advanced Breast Cancer Therapies",
      "score": 0.9981
    },
    {
      "id": "T10755",
      "display_name": "HER2/EGFR in Cancer Research",
      "score": 0.9978
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1158/1538-7445.sabcs22-pd7-03",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:22:15.964769",
  "source_database": "OpenAlex"
}